These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 18207124

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nocardia keratitis: clinical course and effect of corticosteroids.
    Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR.
    Am J Ophthalmol; 2012 Dec; 154(6):934-939.e1. PubMed ID: 22959881
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
    Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, O'Brien KS, Glidden DV, Ray KJ, Oldenburg CE, Zegans ME, Whitcher JP, McLeod SD, Porco TC, Lietman TM, Acharya NR, Steroids for Corneal Ulcers Trial Group.
    Am J Ophthalmol; 2014 Feb; 157(2):327-333.e3. PubMed ID: 24315294
    [Abstract] [Full Text] [Related]

  • 8. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
    Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR.
    Invest Ophthalmol Vis Sci; 2012 Jan 25; 53(1):267-72. PubMed ID: 22159005
    [Abstract] [Full Text] [Related]

  • 9. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.
    Ray KJ, Prajna L, Srinivasan M, Geetha M, Karpagam R, Glidden D, Oldenburg CE, Sun CQ, McLeod SD, Acharya NR, Lietman TM.
    JAMA Ophthalmol; 2013 Mar 25; 131(3):310-3. PubMed ID: 23307105
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
    Oldenburg CE, Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Borkar DS, Ray KJ, Zegans ME, McLeod SD, Porco TC, Lietman TM, Acharya NR.
    Ophthalmic Epidemiol; 2013 Jun 25; 20(3):155-8. PubMed ID: 23662986
    [Abstract] [Full Text] [Related]

  • 12. Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.
    McClintic SM, Prajna NV, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Oldenburg CE, O'Brien KS, Ray KJ, Acharya NR, Lietman TM, Keenan JD.
    Invest Ophthalmol Vis Sci; 2014 May 02; 55(5):2935-40. PubMed ID: 24618327
    [Abstract] [Full Text] [Related]

  • 13. Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.
    Borkar DS, Fleiszig SM, Leong C, Lalitha P, Srinivasan M, Ghanekar AA, Tam C, Li WY, Zegans ME, McLeod SD, Lietman TM, Acharya NR.
    JAMA Ophthalmol; 2013 Feb 02; 131(2):147-53. PubMed ID: 23411878
    [Abstract] [Full Text] [Related]

  • 14. Visual recovery in treated bacterial keratitis.
    Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Ray KJ, Zegans ME, Acharya NR, Lietman TM, Keenan JD, Steroids for Corneal Ulcers Trial Group.
    Ophthalmology; 2014 Jun 02; 121(6):1310-1. PubMed ID: 24612976
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Corticosteroids for bacterial corneal ulcers.
    Srinivasan M, Lalitha P, Mahalakshmi R, Prajna NV, Mascarenhas J, Chidambaram JD, Lee S, Hong KC, Zegans M, Glidden DV, McLeod S, Whitcher JP, Lietman TM, Acharya NR.
    Br J Ophthalmol; 2009 Feb 02; 93(2):198-202. PubMed ID: 18829631
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR.
    Ophthalmology; 2007 Sep 02; 114(9):1622-9. PubMed ID: 17822972
    [Abstract] [Full Text] [Related]

  • 18. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
    Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM, Mycotic Ulcer Treatment Trial Group.
    Ophthalmology; 2014 Aug 02; 121(8):1495-500.e1. PubMed ID: 24746358
    [Abstract] [Full Text] [Related]

  • 19. Early addition of topical corticosteroids in the treatment of bacterial keratitis.
    Ray KJ, Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Glidden DV, Oldenburg CE, Sun CQ, Zegans ME, McLeod SD, Acharya NR, Lietman TM.
    JAMA Ophthalmol; 2014 Jun 02; 132(6):737-41. PubMed ID: 24763755
    [Abstract] [Full Text] [Related]

  • 20. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial.
    See CW, Srinivasan M, Saravanan S, Oldenburg CE, Esterberg EJ, Ray KJ, Glaser TS, Tu EY, Zegans ME, McLeod SD, Acharya NR, Lietman TM.
    Ophthalmic Epidemiol; 2012 Dec 02; 19(6):407-13. PubMed ID: 23171211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.